T-knife GmbH

T-Knife GmbH develops biopharmaceutical therapies for cancer treatment. The Company advances a pipeline of product candidates targeting tumor antigens and engineers fully human, tumor-specific T cell receptors using proprietary platforms. T-knife serves solid tumor cancer patients and their families in Europe, Germany, and the United States.